FDA Alerts
FDA Alerts
07/29/2016
The FDA has approved lixisenatide as an adjunct to diet and exercise for the treatment of adults with type 2 diabetes.
07/29/2016
FDA Alerts
FDA Alerts
07/29/2016
The FDA has approved lixisenatide as an adjunct to diet and exercise for the treatment of adults with type 2 diabetes.
07/29/2016
FDA Alerts
FDA Alerts
07/29/2016
The FDA has approved lixisenatide as an adjunct to diet and exercise for the treatment of adults with type 2 diabetes.
07/29/2016
FDA Alerts
FDA Alerts
07/27/2016
FDA Alerts
FDA Alerts
07/26/2016
The FDA has approved a new treatment option for patients with genotype 1 chronic hepatitis C virus.
07/26/2016
FDA Alerts
FDA Alerts
07/26/2016
The FDA has approved a new treatment option for patients with genotype 1 chronic hepatitis C virus.
07/26/2016
FDA Alerts
FDA Alerts
07/26/2016
The FDA has approved a new treatment option for patients with genotype 1 chronic hepatitis C virus.
07/26/2016
roundup
roundup
07/21/2016
The FDA has approved generic forms of rosuvastatin and a new option for dry eye disease and has heard recommendations to approve a new psoriasis drug.
07/21/2016
FDA
FDA
07/20/2016
The FDA has approved a treatment for hereditary angioedema attacks in pediatric patients.
07/20/2016
FDA
FDA
07/20/2016
The FDA has approved a treatment for hereditary angioedema attacks in pediatric patients.
07/20/2016